Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.4M Buy
61,499
+6,114
+11% +$706K 0.13% 86
2025
Q4
$5.83M Sell
55,385
-94,232
-63% -$8.85M 0.12% 88
2025
Q3
$12.6M Sell
149,617
-106,463
-42% -$8.77M 0.16% 111
2025
Q2
$20.3M Buy
256,080
+168,791
+193% +$13.4M 0.23% 88
2025
Q1
$7.84M Buy
87,289
+34,581
+66% +$3.23M 0.11% 114
2024
Q4
$5.24M Sell
52,708
-2,708
-5% -$279K 0.09% 138
2024
Q3
$6.29M Sell
55,416
-15,218
-22% -$1.81M 0.12% 91
2024
Q2
$8.74M Sell
70,634
-42,935
-38% -$5.53M 0.17% 85
2024
Q1
$15M Sell
113,569
-438,456
-79% -$54M 0.26% 69
2023
Q4
$60.2M Buy
552,025
+470,962
+581% +$48.9M 0.97% 25
2023
Q3
$8.35M Sell
81,063
-134,833
-62% -$14.5M 0.15% 100
2023
Q2
$24.9M Buy
215,896
+117,002
+118% +$13.3M 0.45% 57
2023
Q1
$10.5M Sell
98,894
-281,005
-74% -$30.3M 0.22% 81
2022
Q4
$42.1M Buy
379,899
+18,879
+5% +$1.93M 1.09% 24
2022
Q3
$31.1M Buy
361,020
+239,193
+196% +$21.4M 0.9% 27
2022
Q2
$11.1M Sell
121,827
-52,582
-30% -$4.66M 0.33% 64
2022
Q1
$14.3M Buy
174,409
+156,134
+854% +$12.3M 0.37% 60
2021
Q4
$1.4M Sell
18,275
-38,232
-68% -$3.05M 0.04% 215
2021
Q3
$4.24M Buy
56,507
+34,503
+157% +$2.62M 0.12% 129
2021
Q2
$1.69M Sell
22,004
-34,973
-61% -$2.6M 0.05% 199
2021
Q1
$4.19M Sell
56,977
-239,522
-81% -$17.7M 0.13% 114
2020
Q4
$23.1M Buy
296,499
+280,782
+1,786% +$21.5M 0.81% 31
2020
Q3
$1.24M Sell
15,717
-13,583
-46% -$1.06M 0.05% 179
2020
Q2
$2.16M Sell
29,300
-13,819
-32% -$1.04M 0.14% 121
2020
Q1
$3.17M Buy
43,119
+33,151
+333% +$2.61M 0.22% 96
2019
Q4
$865K Sell
9,968
-20,120
-67% -$1.65M 0.07% 146
2019
Q3
$2.42M Sell
30,088
-41,081
-58% -$3.29M 0.17% 106
2019
Q2
$5.69M Buy
71,169
+15,533
+28% +$1.19M 0.44% 50
2019
Q1
$4.42M Sell
55,636
-94,397
-63% -$7.06M 0.36% 59
2018
Q4
$10.9M Buy
+150,033
New +$10.6M 1.64% 12

Other funds holding MRK

Ossiam's MRK Position: Q1 2026 in Review

Ossiam increased its Merck (MRK) stake by 11% in Q1 2026, buying an estimated $706K and bringing the position to 61,499 shares worth $7.4M. The position accounts for 0.13% of the portfolio, ranked #86.

Ossiam first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $60.2M in Q4 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ossiam held 61,499 shares of Merck worth $7.4M as of Q1 2026.
  • Ossiam bought 6,114 Merck shares in Q1 2026, an estimated $706K.
  • Merck made up 0.13% of Ossiam's portfolio in Q1 2026, its #86 holding.
  • Ossiam first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Ossiam's Merck position peaked at $60.2M in Q4 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.